Early in 1998, Risinger et al. [11] found that PTEN mutations are associated with endometrioid histology and other favorable pathologic, clinical, and molecular features rather than with increased metastatic potential, as has been noted in other types of cancers [11]. The gene discussed is PTEN; the disease is cancer.